Request for Covid-19 Impact Assessment of this Report
The market for neuro-oncological diagnosis devices is most developed in the North American and European region owing to the funds that government provides for research and development of high-quality neuro-oncological diagnosis devices. The market for the devices is also increasing rapidly in Asia Pacific due to new policies of governments which fascinates manufacturers for manufacturing neuro-oncological diagnosis devices in these countries. Neuro-oncological diagnosis device usage is obligatory in the diagnosis of fatal diseases. Therefore, many under-developed economies of middle east and Africa also have a large market for neuro-oncological diagnosis devices.
This report provides a complete quantitative data and qualitative analysis on the global market for Neuro-Oncological Diseases Device. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Neuro-Oncological Diseases Device was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Neuro-Oncological Diseases Device is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Neuro-Oncological Diseases Device, including the following market information:
Global Neuro-Oncological Diseases Device Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (Units)
Global Neuro-Oncological Diseases Device Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (Units)
Global Neuro-Oncological Diseases Device Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (Units)
Global Neuro-Oncological Diseases Device Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (Units)
Key market players
Major competitors identified in this market include Siemens Healthcare, Philips Healthcare, Canon Medical Systems, GE Healthcare, Hitachi Medical, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
MRI
CT Scan
PET
Others
Based on the Application:
Hospitals
Clinics
Diagnostics Centers
Reference Laboratories
Medical Research Institutes
Others
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Neuro-Oncological Diseases Device Industry
1.7 COVID-19 Impact: Neuro-Oncological Diseases Device Market Trends
2 Global Neuro-Oncological Diseases Device Quarterly Market Size Analysis
2.1 Neuro-Oncological Diseases Device Business Impact Assessment - COVID-19
2.1.1 Global Neuro-Oncological Diseases Device Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Neuro-Oncological Diseases Device Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Neuro-Oncological Diseases Device Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Neuro-Oncological Diseases Device Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Neuro-Oncological Diseases Device Factory Price by Manufacturers
3.3 Location of Key Manufacturers Neuro-Oncological Diseases Device Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Neuro-Oncological Diseases Device Market
3.5 Key Manufacturers Neuro-Oncological Diseases Device Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Neuro-Oncological Diseases Device Segments, By Type
4.1 Introduction
1.4.1 MRI
1.4.2 CT Scan
1.4.3 PET
1.4.4 Others
4.2 By Type, Global Neuro-Oncological Diseases Device Market Size, 2019-2021
4.2.1 By Type, Global Neuro-Oncological Diseases Device Market Size by Type, 2020-2021
4.2.2 By Type, Global Neuro-Oncological Diseases Device Price, 2020-2021
5 Impact of Covid-19 on Neuro-Oncological Diseases Device Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Clinics
5.5.3 Diagnostics Centers
5.5.4 Reference Laboratories
5.5.5 Medical Research Institutes
5.5.6 Others
5.2 By Application, Global Neuro-Oncological Diseases Device Market Size, 2019-2021
5.2.1 By Application, Global Neuro-Oncological Diseases Device Market Size by Application, 2019-2021
5.2.2 By Application, Global Neuro-Oncological Diseases Device Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Siemens Healthcare
7.1.1 Siemens Healthcare Business Overview
7.1.2 Siemens Healthcare Neuro-Oncological Diseases Device Quarterly Production and Revenue, 2020
7.1.3 Siemens Healthcare Neuro-Oncological Diseases Device Product Introduction
7.1.4 Siemens Healthcare Response to COVID-19 and Related Developments
7.2 Philips Healthcare
7.2.1 Philips Healthcare Business Overview
7.2.2 Philips Healthcare Neuro-Oncological Diseases Device Quarterly Production and Revenue, 2020
7.2.3 Philips Healthcare Neuro-Oncological Diseases Device Product Introduction
7.2.4 Philips Healthcare Response to COVID-19 and Related Developments
7.3 Canon Medical Systems
7.3.1 Canon Medical Systems Business Overview
7.3.2 Canon Medical Systems Neuro-Oncological Diseases Device Quarterly Production and Revenue, 2020
7.3.3 Canon Medical Systems Neuro-Oncological Diseases Device Product Introduction
7.3.4 Canon Medical Systems Response to COVID-19 and Related Developments
7.4 GE Healthcare
7.4.1 GE Healthcare Business Overview
7.4.2 GE Healthcare Neuro-Oncological Diseases Device Quarterly Production and Revenue, 2020
7.4.3 GE Healthcare Neuro-Oncological Diseases Device Product Introduction
7.4.4 GE Healthcare Response to COVID-19 and Related Developments
7.5 Hitachi Medical
7.5.1 Hitachi Medical Business Overview
7.5.2 Hitachi Medical Neuro-Oncological Diseases Device Quarterly Production and Revenue, 2020
7.5.3 Hitachi Medical Neuro-Oncological Diseases Device Product Introduction
7.5.4 Hitachi Medical Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Neuro-Oncological Diseases Device Supply Chain Analysis
8.1.1 Neuro-Oncological Diseases Device Supply Chain Analysis
8.1.2 Covid-19 Impact on Neuro-Oncological Diseases Device Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Neuro-Oncological Diseases Device Distribution Channels
8.2.2 Covid-19 Impact on Neuro-Oncological Diseases Device Distribution Channels
8.2.3 Neuro-Oncological Diseases Device Distributors
8.3 Neuro-Oncological Diseases Device Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Neuro-Oncological Diseases Device Assessment
Table 9. COVID-19 Impact: Neuro-Oncological Diseases Device Market Trends
Table 10. COVID-19 Impact Global Neuro-Oncological Diseases Device Market Size
Table 11. Global Neuro-Oncological Diseases Device Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (Units)
Table 12. Global Neuro-Oncological Diseases Device Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Neuro-Oncological Diseases Device Quarterly Market Size, 2020 (US$ Million) & (Units)
Table 14. Global Neuro-Oncological Diseases Device Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Neuro-Oncological Diseases Device Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (Units)
Table 16. Global Neuro-Oncological Diseases Device Market Growth Drivers
Table 17. Global Neuro-Oncological Diseases Device Market Restraints
Table 18. Global Neuro-Oncological Diseases Device Market Opportunities
Table 19. Global Neuro-Oncological Diseases Device Market Challenges
Table 20. Key Manufacturers Neuro-Oncological Diseases Device Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Neuro-Oncological Diseases Device Market Size, 2019 (Units) & (US$ Million)
Table 22. Neuro-Oncological Diseases Device Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Neuro-Oncological Diseases Device Manufacturing Plants
Table 24. Key Manufacturers Neuro-Oncological Diseases Device Market Served
Table 25. Date of Key Manufacturers Enter into Neuro-Oncological Diseases Device Market
Table 26. Key Manufacturers Neuro-Oncological Diseases Device Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Neuro-Oncological Diseases Device Market Size by Type, 2020, (US$ Million)
Table 29. Global Neuro-Oncological Diseases Device Market Size by Type, 2020 (Units)
Table 30. Global Neuro-Oncological Diseases Device Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Neuro-Oncological Diseases Device Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Neuro-Oncological Diseases Device Market Size by Application, 2020-2021 (Units)
Table 33. Global Neuro-Oncological Diseases Device Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Neuro-Oncological Diseases Device Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Neuro-Oncological Diseases Device Market Size by Region, 2019-2021 (Units)
Table 36. By Country, North America Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Neuro-Oncological Diseases Device Market Size, 2019-2021 (Units)
Table 38. US Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 39. Canada Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Neuro-Oncological Diseases Device Market Size, 2019-2021 (Units)
Table 43. Germany Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 44. France Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 45. UK Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 46. Italy Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Neuro-Oncological Diseases Device Market Size, 2019-2021 (Units)
Table 50. China Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 51. Japan Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 52. South Korea Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 53. India Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 54. ASEAN Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 55. Latin America Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 56. Middle East and Africa Neuro-Oncological Diseases Device Market Size, 2019-2021 (US$ Million) & (Units)
Table 57. Siemens Healthcare Business Overview
Table 58. Siemens Healthcare Neuro-Oncological Diseases Device Production (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Siemens Healthcare Neuro-Oncological Diseases Device Product
Table 60. Siemens Healthcare Response to COVID-19 and Related Developments
Table 61. Philips Healthcare Business Overview
Table 62. Philips Healthcare Neuro-Oncological Diseases Device Production (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Philips Healthcare Neuro-Oncological Diseases Device Product
Table 64. Philips Healthcare Response to COVID-19 and Related Developments
Table 65. Canon Medical Systems Business Overview
Table 66. Canon Medical Systems Neuro-Oncological Diseases Device Production (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Canon Medical Systems Neuro-Oncological Diseases Device Product
Table 68. Canon Medical Systems Response to COVID-19 and Related Developments
Table 69. GE Healthcare Business Overview
Table 70. GE Healthcare Neuro-Oncological Diseases Device Production (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. GE Healthcare Neuro-Oncological Diseases Device Product
Table 72. GE Healthcare Response to COVID-19 and Related Developments
Table 73. Hitachi Medical Business Overview
Table 74. Hitachi Medical Neuro-Oncological Diseases Device Production (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Hitachi Medical Neuro-Oncological Diseases Device Product
Table 76. Hitachi Medical Response to COVID-19 and Related Developments
Table 77. Neuro-Oncological Diseases Device Distributors List
Table 78. Neuro-Oncological Diseases Device Customers List
Table 79. Covid-19 Impact on Neuro-Oncological Diseases Device Customers
List of Figures
Figure 1. Neuro-Oncological Diseases Device Product Picture
Figure 2. Neuro-Oncological Diseases Device Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Neuro-Oncological Diseases Device Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Neuro-Oncological Diseases Device Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Neuro-Oncological Diseases Device Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Neuro-Oncological Diseases Device Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Neuro-Oncological Diseases Device Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Neuro-Oncological Diseases Device Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Neuro-Oncological Diseases Device Market Size Market Share, 2019-2021
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...